Danilo D’Alessandro
Fortuna: 1 M $ al 31/05/2026
Fortuna: 1 M $ al 31/05/2026
Danilo D’Alessandro is currently Chief Financial Officer & Head-Investor Relations at ClearPoint Neuro, Inc. since 2021.
Formerly, worked at Koninklijke Philips NV as Head-Finance Therapy Devices Division.
Education includes graduate degree from the University of Bath and undergraduate degree from the University of Bocconi.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
CLEARPOINT NEURO, INC. 0,34 % | 23/03/2026 | 102.684 ( 0,34 % ) | 1 M $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| CLEARPOINT NEURO, INC. | Director Financiero/CFO | 01/01/2021 |
| Empresas | Cargo | Fin |
|---|---|---|
| PHILIPS NV | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Koninklijke Philips NV
Koninklijke Philips NV Medical/Nursing ServicesHealth Services Provides image, cardiovascular, diagnostic imaging, ambulatory, sleep therapy and personal healthcare services | Health Services |
University of Bath
University of Bath Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Bocconi
University of Bocconi Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Clearpoint Neuro, Inc.
Clearpoint Neuro, Inc. Medical SpecialtiesHealth Technology Develops and markets bio technology and surgical products | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.